BME Colloquium: Friday 5/2/08
05/02/2008
Success in biotechnology – what is it and how long does it take?
Jonathan P. Mow
VP Business Development
Amylin Pharmaceuticals
From 1976 to 2005, the U.S. biotech industry grew from one company to more than 1400 with a total market capitalization of >$400B and spending of approximately $20B per year on research and development. All of these companies were started with variants of a single mission – to improve human health and quality of life.
Amylin Pharmaceuticals was started in 1987, went public in 1992, and has developed and commercialized 2 products for diabetes - both launched in 2005. In this lecture Mr. Mow will present his perspective on successes in the biotech industry and how these lessons apply to Amylin and opportunities within the industry. He will also describe the role of business development and provide commentary on his formal education in mechanical engineering and business and its relevance to his career.
Mr. Mow has served as our Vice President, Business Development since March 2007. Prior to joining Amylin, Mr. Mow was Co-founder, Vice President, Commercial and Business Development, and Secretary of Corus Pharma, Inc. until their acquisition by Gilead Sciences in 2006. From 1997 to 2000, Mr. Mow led the Business Development efforts for PathoGenesis Corporation, culminating with the company’s acquisition by Chiron Corporation in 2000. From 1995 to 1997, he was Associate Director, Worldwide Oncology Marketing and Strategic Business Planning at Bristol Myers-Squibb. Earlier Mr. Mow held various positions in Marketing and Sales at Wyeth/Lederle International and Syntex Laboratories. He also serves as a board member for AerovectRx Corporation. Mr. Mow received his B.S. in Mechanical Engineering from the University of California, Berkeley and his M.B.A. from the Tepper School of Management at Carnegie Mellon University.
Contact: Prof. Samuel Sia,
Day/Time: Fridays, 11:00–12:00 noon
|
Room |
Date |
Speaker |
|
614SH |
Feb 8 |
Elise Morgan, Boston University |
|
ET |
Feb 15 |
Aniruddha Das, Columbia University |
|
ET |
Feb 22 |
BME Research (Hillman, Guo) |
|
ET |
Feb 29 |
BME Research (Mao, Konofagou) |
|
614SH |
Mar 7 |
Thomas Thesen, New York University |
|
614SH |
Mar 14 |
Laura Kaufman, Columbia University |
|
ET |
Apr 4 |
Edo Kussell, New York University |
| 614SH | Apr 11 |
Susannah Friton, CCNY |
| 614SH | Apr 18 | Tom Andriacchi, Stanford University |
| 614SH | Apr 25 | Bruce Rosen, Massachusetts General Hospital |
|
|
||
| CEPSR Intershcool Lab, 7th Fl | May 2 | Jonathan Mow, Amylin Pharmaceuticals |
ET = DBME Conference room, Engineering Terrace
614SH = 614 Schermerhorn